Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity
investors.com/news/technology/acadia-pharmaceuticals-alzheimers-disease-psychosis-prader-willi-catherine-owen-adams
Acadia Pharmaceuticals is working on its next-generation Nuplazid and, for CEO Catherine Owen Adams, the journey is personal.
The post Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity appeared first on Investor's Business Daily.
This story appeared on investors.com, 2025-07-10 12:00:50.